Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 785
Filter
1.
An. bras. dermatol ; 96(5): 578-580, Sept.-Oct. 2021. graf
Article in English | LILACS | ID: biblio-1345151

ABSTRACT

Abstract Skin metastases are rare and may occur in the context of a known metastatic disease or be the first clinical sign of an underlying primary tumor. In the case of carcinoid neoplasms, determining whether the cutaneous tumor is primary or secondary and identifying the tumor origin in metastatic cases is not always an easy task. This is the report of a case of cutaneous metastasis presenting as the first clinical manifestation of a previously unknown pulmonary carcinoid tumor, including the discussion of histopathological and immunohistochemical findings that allowed an adequate diagnosis of the tumor etiology and reinforces the importance for dermatologists and dermatopathologists to be familiar with these findings.


Subject(s)
Humans , Skin Neoplasms , Carcinoid Tumor/diagnosis , Lung Neoplasms
2.
Chinese Journal of Lung Cancer ; (12): 784-789, 2021.
Article in Chinese | WPRIM | ID: wpr-922147

ABSTRACT

Pulmonary neuroendocrine tumors (PNETs) are a kind of epithelial tumors originating from pulmonary neuroendocrine cells, accounting for about 20% of primary lung tumors, including typical carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma. The morphologic and clinical characteristics of these four types of PNETs are relatively highly heterogeneous. Immune checkpoint inhibitors (ICIs) have been shown robust antitumor activity in a variety of solid tumors. Treatment regimens of advanced PNETs have developed greatly in the past decade, but ICIs are still in their infancy in the field of PNETs. This review focuses on the landscape of current clinical trials and research as well as the situation of ICIs-related biomarkers in PNETs.
.


Subject(s)
Carcinoid Tumor , Carcinoma, Neuroendocrine , Humans , Immune Checkpoint Inhibitors , Lung Neoplasms/drug therapy , Neuroectodermal Tumors, Primitive , Neuroendocrine Tumors/drug therapy
3.
Chinese Journal of Lung Cancer ; (12): 847-852, 2021.
Article in Chinese | WPRIM | ID: wpr-922137

ABSTRACT

BACKGROUND@#The curative potential of various bronchoscopic treatments such as electric snare, carbon dioxide freezing, argon plasma coagulation (APC), Neudymium-dopted Yttrium Aluminium Garnet (Nd:YAG) laser and photodynamic therapy (PDT) for the treatment of intraluminal tumor has been administered previously, but this regimen is not common in the treatment of typical carcinoid. The aim of this study is to investigate the curative effects both in short-term and long-term of interventional bronchoscopy in the treatment of typical carcinoid.@*METHODS@#We retrospectively reviewed the clinical data of typical carcinoid patients who were treated with interventional bronchoscopy for tumor suppression and they were hospitalized in the Emergency General Hospital from December 2010 to December 2020, and Wilcoxon rank sum test and chi-square test were used for analysis.@*RESULTS@#A total of 32 patients were included, including 18 cases of preoperative bronchial artery embolization (embolization rate 56%, 95%CI: 31%-79%). The grade score of dyspnea decreased from before treatment to after treatment, and the difference was statistically significant [(1.44±1.03) score vs (0.25±0.58) score, P=0.003]; The degree of bronchial stenosis decreased from pre-treatment to post-treatment, and the difference was statistically significant [(87.50%±13.90%) vs (17.50%±6.83%), P<0.001]; There was significant difference in bronchial diameter before and after treatment [(0.14±0.18) cm vs (0.84±0.29) cm, P<0.001].@*CONCLUSIONS@#Bronchoscopic interventional therapy has significant short-term and long-term effects in the treatment of typical carcinoid.


Subject(s)
Bronchial Neoplasms/surgery , Bronchoscopy , Carcinoid Tumor/surgery , Humans , Neuroendocrine Tumors , Retrospective Studies
4.
Chinese Journal of Oncology ; (12): 989-1000, 2021.
Article in Chinese | WPRIM | ID: wpr-920980

ABSTRACT

Lung and thymus neuroendocrine neoplasms (NENs) are rare tumors. According to the fifth edition of the World Health Organization classification of thoracic tumors published in 2021, lung and thymus NENs include typical carcinoids, atypical carcinoids, large cell neuroendocrine carcinomas, and small cell carcinomas. Although the incidence of lung and thymus NENs has gradually increased in recent years, there is a lack of randomized controlled clinical study results to guide clinical practice. The treatment of early-stage lung and thymus NENs is complete surgical resection, and the treatment methods for unresectable advanced diseases include different medical treatments, peptide receptor radionuclide therapy, and local therapy. To improve the standardization of diagnosis and treatment of lung and thymus NENs in China, the Expert Committee of Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology developed the expert consensus after multidisciplinary expert discussions based on existing clinical study evidences and guidelines from different neuroendocrine tumor societies. The contents of the consensus cover the epidemiology, diagnosis, pathological classification, staging, treatment and follow-up of lung and thymus NENs (except small cell lung cancer).


Subject(s)
Carcinoid Tumor , China , Consensus , Humans , Lung , Neuroendocrine Tumors/therapy
5.
Rev. chil. radiol ; 26(3): 120-124, set. 2020. ilus
Article in Spanish | LILACS | ID: biblio-1138707

ABSTRACT

Resumen: Los tumores neuroendocrinos primarios (NET) del mediastino son muy raros. Presentamos el caso de un tumor carcinoide atípico primario de timo. Un hombre de 52 años que fue a un examen médico porque se quejaba de tos no productiva sin hemoptisis. Se solicitó una radiografía de tórax donde se evidenció un mediastino notablemente ensanchado, con una tomografía de tórax que mostro una masa tumoral de 90 x 50 mm en el mediastino anterosuperior que comprime el arco aórtico y la arteria pulmonar sin un plano de clivaje adecuado. Debido a que el tumor era infiltrativo, se proporcionó escisión quirúrgica completa, quimioterapia y radioterapia al mediastino. El objetivo principal de nuestro estudio fue evaluar los hallazgos de CT y MRI con relación a la literatura mundial.


Abstract: Primary neuroendocrine tumors (NET) of the mediastinum are very rare. We present the case of a primary atypical carcinoid tumor of the thymus. A 52-year-old man who went to a medical examination because he complained of a non-productive cough without hemoptysis. A chest radiograph was requested where a markedly widened mediastinum was evidenced, with a thoracic tomography showing a tumor mass of 90 x 50 mm in the anterosuperior mediastinum that compresses the aortic arch and pulmonary artery without an adequate cleavage plane. Because the tumor was infiltrative, complete surgical excision, chemotherapy and radiotherapy were provided to the mediastinum. The main objective of our study was to evaluate the findings of CT and MRI in relation to universal literature.


Subject(s)
Humans , Male , Middle Aged , Thymus Neoplasms/diagnostic imaging , Carcinoid Tumor/diagnostic imaging , Neuroendocrine Tumors/diagnostic imaging , Thymus Neoplasms/surgery , Carcinoid Tumor/surgery , Radiography, Thoracic , Tomography, X-Ray Computed , Neuroendocrine Tumors/surgery , Mediastinum/pathology
6.
Arq. bras. med. vet. zootec. (Online) ; 72(3): 1063-1066, May-June, 2020. ilus
Article in Portuguese | LILACS, VETINDEX | ID: biblio-1129774

ABSTRACT

Carcinoid is a neoplasia that arises from dispersed cells of the neuroendocrine system. This tumor is uncommon in animals, and its occurrence in the gallbladder is rare. A male Basset Hound dog's corpse was taken to the Univerdade Federal de Minas Gerais to be analyzed by the Veterinary Pathology sector, without a description of its previous history. Necropsy revealed the presence of pale oral, ocular and penile mucous membranes. The gallbladder had a thickened wall and a dilated lumen, which was filled with dark and lumpy bile. Its mucosa had a whitish-red nodule, with solid and friable areas. Microscopically, there was a focal neoplastic proliferation, which wasn't encapsulated and had imprecise limits, which cells were distributed in a solid pattern and separated by a delicate fibrovascular stroma. The neoplastic cells presented oval or round shaped nucleus, which had a chromatin predominantly loose, and one or two nucleoli. Their cytoplasm was moderately abundant, and in most of the cells it was eosinophilic, granular, and had well-defined limits. Using the Grimelius coloration, neoplastic cells' cytoplasmic granules stained brownish or black, confirming the neuroendocrine origin of the neoplasia. Based on the macroscopic and microscopic findings, the diagnosis of a gallbladder carcinoid was established.(AU)


Subject(s)
Animals , Male , Dogs , Carcinoid Tumor/veterinary , Carcinoma, Neuroendocrine/veterinary , Gallbladder/pathology , Gallbladder Neoplasms/veterinary
7.
ARS med. (Santiago, En línea) ; 44(4): 31-34, dic-2019. Caso clínico
Article in Spanish | LILACS | ID: biblio-1145764

ABSTRACT

Los tumores neuroendocrinos primarios del testículo son una entidad muy infrecuente, dando cuenta del 1% de las neoplasias testicu-lares. Clínicamente se presentan indolentes, por una masa testicular. En tumores localizados, rara vez presentan síndrome carcinoide. La orquiectomía radical es el tratamiento de elección; el pronóstico es excelente en etapas precoces. Las terapias adyuvantes no han mostrado utilidad.Se presenta un caso de un hombre de 53 años con una masa testicular palpable de larga evolución. Se realiza orquiectomía radical. La biopsia muestra un tumor neuroendocrino bien diferenciado. Sin evidencia de metástasis en etapificación. Se define en comité onco-lógico, realizar seguimiento.


Subject(s)
Testis , Carcinoid Tumor , Neoplasms , Neurosecretory Systems
9.
J. coloproctol. (Rio J., Impr.) ; 39(2): 184-189, Apr.-June 2019. graf
Article in English | LILACS | ID: biblio-1012596

ABSTRACT

ABSTRACT The authors present a case of rectal carcinoid tumor in an asymptomatic patient who sought a coloproctology service with the purpose of colorectal cancer prevention. During colonoscopy, a polyp lesion was found in the rectum, and it was resected with a polypectomy loop. Anatomopathological examination revealed a rectal carcinoid tumor with compromised margins. The lesion site was resected again and pathological exam no longer showed neoplasia. A systematic review of the issue was performed, discussing diagnosis aspects, difficulties in the choice of therapeutic approaches, and prognosis. The conclusion is that the rarity of the disease brings difficulties in the choice of treatment; although it has a good prognosis in most cases, its malignant potential cannot be underestimated.


RESUMO Apresentamos um caso clínico de um tumor carcinóide de reto em um paciente assintomático que procurou um serviço de colo-proctologia com o objetivo de fazer prevenção ao câncer colorretal. Durante a colonoscopia observou-se uma lesão polipóide no reto, a qual foi ressecada com alça de polipectomia. O exame anatomopatológico evidenciou tumor carcinóide de reto com comprometimento de margem. O local foi novamente ressecado e o resultado patológico não mais evidenciou neoplasia. Neste artigo é feita uma revisão bibliográfica do assunto abordando aspectos diagnósticos, dificuldade na escolha da conduta terapêutica e prognóstica. O trabalho conclui que a raridade do caso implica em dificuldades na escolha da conduta e que apesar de ter bom prognóstico, em uma parcela dos casos o seu potencial maligno não deve ser desprezado.


Subject(s)
Humans , Male , Middle Aged , Rectal Neoplasms , Carcinoid Tumor/diagnosis , Neuroendocrine Tumors/diagnosis
10.
Oncol. (Guayaquil) ; 29(1): 27-35, 30 de abril 2019.
Article in Spanish | LILACS | ID: biblio-1000444

ABSTRACT

Introducción: Los tumores neuroendocrinos (TNE) son un grupo de neoplasias que se originan a partir de células enterocromafínicas, especialmente ubicadas en el tubo digestivo. El objetivo del presente estudio es escribir la distribución topográfica, el manejo multidisciplinario y diagnóstico patológico según la OMS de los tumores neuroendocrinos del tubo digestivo. Métodos: El presente es un estudio descriptivo, retrospectivo de los casos con diagnóstico anatomopatológico confirmado de tumor neuroendocrino localizados en el tubo digestivo entre enero del 2011 a diciembre del 2018 en el Instituto Oncológico Nacional del Ecuador- SOLCA de Guayaquil. Se describe topografía y tipo de tratamiento establecido con frecuencias y porcentajes. Resultados: Ingresaron al estudio 21 casos. La localización más frecuente fue el apéndice cecal n = 8 (38 %), en estómago n=4 (19 %), intestino delgado n=3 (14 %). El diagnóstico patológico en estadio G1 (65 %); G2 (24%) y G3 (12%). La primera línea de tratamiento fue la cirugía con intención curativa n=19 (90.5 %) y tratamiento endoscópico n=2 (9.5 %). Los pacientes sometidos a cirugía, n=16/19; (84 %) obtuvieron niveles de resección 0 (R0) y permanecieron en observación clínica, los demás sujetos en el estudio recibieron tratamiento adyuvante con somatostatina sola n=1 (4.8 %) o combinación de somatostatina y radioterapia n=2 (9.5 %). Conclusión: El diagnóstico de tumor neuroendocrino de tubo digestivo es una etiología oncológica poco frecuente. El tratamiento quirúrgico en esta serie de casos está enfocada en una acción curativa de tipo quirúrgico.


Introduction: Neuroendocrine tumors (NETs) are a group of neoplasms that originate from enterochromaffin cells, especially located in the digestive tract. The objective of the present study is to write the topographic distribution, the multidisciplinary management and pathological diagnosis according to the WHO of the neuroendocrine tumors of the digestive tract. Methods: This is a descriptive, retrospective study of the cases with a confirmed anatomopathological diagnosis of neuroendocrine tumor located in the digestive tract between January 2011 to December 2018 at the National Oncology Institute of Ecuador- SOLCA of Guayaquil. The topography and type of treatment established with frequencies and percentages are described. Results: 21 cases were entered into the study. The most frequent location was the cecal appendix n = 8 (38%), stomach n = 4 (19%), small intestine n = 3 (14%). The pathological diagnosis in stage G1 (65%); G2 (24%) and G3 (12%). The first line of treatment was surgery with curative intent n = 19 (90.5%) and endoscopic treatment n = 2 (9.5%). Patients undergoing surgery, n = 16/19; (84%) obtained resection levels 0 (R0) and remained under clinical observation, the other subjects in the study received adjuvant treatment with somatostatin alone n = 1 (4.8%) or combination of somatostatin and radiotherapy n = 2 (9.5%). Conclusion: The diagnosis of neuroendocrine tumor of the digestive tract is a rare oncological etiology. The surgical treatment in this series of cases is focused on a surgical action of a surgical type.


Subject(s)
Humans , Carcinoid Tumor , Gastrointestinal Tract , Lower Gastrointestinal Tract , Appendix , Carcinoma, Neuroendocrine , Upper Gastrointestinal Tract
11.
J. bras. pneumol ; 45(5): e20180140, 2019. tab, graf
Article in English | LILACS | ID: biblio-1040277

ABSTRACT

ABSTRACT Objective: To analyze determinants of prognosis in patients with bronchial carcinoid tumors treated surgically and the potential concomitance of such tumors with second primary neoplasms. Methods: This was a retrospective analysis of 51 bronchial carcinoid tumors treated surgically between 2007 and 2016. Disease-free survival (DFS) was calculated by the Kaplan-Meier method, and determinants of prognosis were evaluated. Primary neoplasms that were concomitant with the bronchial carcinoid tumors were identified by reviewing patient charts. Results: The median age was 51.2 years, 58.8% of the patients were female, and 52.9% were asymptomatic. The most common histology was typical carcinoid (in 80.4%). Five-year DFS was 89.8%. Ki-67 expression was determined in 27 patients, and five-year DFS was better among the patients in whom Ki-67 expression was ≤ 5% than among those in whom it was > 5% (100% vs. 47.6%; p = 0.01). Concomitant primary neoplasms were observed in 14 (27.4%) of the 51 cases. Among the concomitant primary neoplasms that were malignant, the most common was lung adenocarcinoma, which was observed in 3 cases. Concomitant primary neoplasms were more common in patients who were asymptomatic and in those with small tumors. Conclusions: Surgical resection is the mainstay treatment of bronchopulmonary carcinoid tumors and confers a good prognosis. Bronchial carcinoid tumors are likely to be accompanied by second primary neoplasms.


RESUMO Objetivo: Analisar os determinantes do prognóstico em pacientes com tumores carcinoides brônquicos tratados cirurgicamente e possível segunda neoplasia primária concomitante. Métodos: Trata-se de uma análise retrospectiva de 51 tumores carcinoides brônquicos tratados cirurgicamente entre 2007 e 2016. A sobrevida livre de doença (SLD) foi calculada pelo método de Kaplan-Meier, e os determinantes do prognóstico foram avaliados. As neoplasias primárias concomitantes aos tumores carcinoides brônquicos foram identificadas por meio da análise dos prontuários dos pacientes. Resultados: A mediana de idade foi de 51,2 anos, 58,8% dos pacientes eram do sexo feminino e 52,9% eram assintomáticos. A classificação histológica mais comum foi carcinoide típico (em 80,4%). A SLD em cinco anos foi de 89,8%. A expressão de Ki-67 foi determinada em 27 pacientes, e a SLD em cinco anos foi melhor nos pacientes nos quais a expressão de Ki-67 foi ≤ 5% do que naqueles nos quais a expressão de Ki-67 foi > 5% (100% vs. 47,6%; p = 0,01). Neoplasias primárias concomitantes foram observadas em 14 (27,4%) dos 51 casos. Entre as neoplasias primárias malignas concomitantes, a mais comum foi o adenocarcinoma pulmonar, observado em 3 casos. Neoplasias primárias concomitantes foram mais comuns em pacientes assintomáticos e naqueles com tumores pequenos. Conclusões: A resseção cirúrgica é o principal tratamento de tumores carcinoides broncopulmonares e propicia um bom prognóstico. É provável que tumores carcinoides brônquicos se relacionem com segunda neoplasia primária.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Bronchial Neoplasms/surgery , Carcinoid Tumor/surgery , Neoplasms, Second Primary/surgery , Time Factors , Bronchial Neoplasms/pathology , Carcinoid Tumor/pathology , Retrospective Studies , Neoplasms, Second Primary/pathology , Statistics, Nonparametric , Disease-Free Survival , Ki-67 Antigen/analysis , Length of Stay
12.
Article in English | WPRIM | ID: wpr-762705

ABSTRACT

PURPOSE: Primary hepatic neuroendocrine tumor (PHNET) is a very rare neoplasm, requiring strict exclusion of metastasis from possible extrahepatic primary sites for its diagnosis. METHODS: We reviewed our clinical experience of 13 patients with primary hepatic NET who underwent liver resection from January 1997 to December 2015. RESULTS: The mean age of the 13 patients (8 males and 5 females) was 51.1 ± 12.8 years; the most common clinical manifestation was vague, nonspecific abdominal pain (n = 9). Of them, 11 patients underwent preoperative liver biopsy, 7 of which correctly diagnosed as neuroendocrine tumor (NET). Ten patients underwent R0 resection, and 3 underwent R1 resection. Diagnosis of PHNET was confirmed both immunohistochemically and by absence of extrahepatic primary sites. All tumors were single lesions, with a mean size of 9.6 ± 7.6 cm and a median size of 4.3 cm; all showed positive staining for synaptophysin and chromogranin. During a mean follow-up period of 95.1 ± 86.6 months, 7 patients died from tumor recurrence, whereas the other 6 remain alive to date, making the 5-year tumor recurrence rate 56.0% and the 5-year patient survival rate 61.5%. When confined to R0 resection, 5-year recurrence and survival rates were 42.9% and 70.0%, respectively. Univariate analysis showed that Ki-67 proliferative index was the only risk factor for tumor recurrence. CONCLUSION: PHNET is a very rare tumor with no specific clinical features, and its final diagnosis depends primarily on pathology, immunohistochemistry, and exclusion of metastasis from other sites. Aggressive surgical treatment is highly recommended for PHNET because of acceptably favorable postresection outcomes.


Subject(s)
Abdominal Pain , Biopsy , Carcinoid Tumor , Diagnosis , Follow-Up Studies , Hepatectomy , Humans , Immunohistochemistry , Liver , Male , Neoplasm Metastasis , Neuroendocrine Tumors , Pathology , Prognosis , Recurrence , Risk Factors , Survival Rate , Synaptophysin
13.
Article in Korean | WPRIM | ID: wpr-738991

ABSTRACT

Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant hereditary disorder caused by germline mutation of the MEN1 gene. It is characterized by tumors of the anterior pituitary gland, parathyroid glands, and endocrine pancreas. Thymic carcinoid tumor is uncommon and associated with a high mortality, but its natural history has not been investigated yet. We report a case of asymptomatic MEN 1 with a thymic carcinoid tumor. A 37-year-old man underwent a routine medical checkup and upper gastrointestinal endoscopy revealed a duodenal neuroendocrine tumor (NET). Further studies showed the coexistence of pancreatic tumor, parathyroid hyperplasia, pituitary adenoma, and thymoma. The patient underwent duodenal endoscopic mucosal resection, distal pancreatectomy, subtotal parathyroidectomy, and thymectomy. The pathological test revealed a duodenal NET, pancreatic NET, parathyroid hyperplasia, and thymic carcinoid tumor. He was treated for MEN 1. We report this asymptomatic case of MEN 1 with a literature review.


Subject(s)
Adult , Carcinoid Tumor , Endoscopy, Gastrointestinal , Germ-Line Mutation , Humans , Hyperparathyroidism , Hyperplasia , Islets of Langerhans , Mortality , Multiple Endocrine Neoplasia Type 1 , Multiple Endocrine Neoplasia , Natural History , Neuroendocrine Tumors , Pancreatectomy , Parathyroid Glands , Parathyroidectomy , Pituitary Gland, Anterior , Pituitary Neoplasms , Thymectomy , Thymoma
14.
Article in English | WPRIM | ID: wpr-786664

ABSTRACT

Atypical thymic carcinoid is an extremely rare tumor with a poor prognosis. In addition to its known association with multiple endocrine neoplasia type 1, its hallmark characteristics include local invasion and early distant metastasis. In this report, we share our experience treating atypical thymic carcinoid in a patient with Zollinger-Ellison syndrome.


Subject(s)
Carcinoid Tumor , Humans , Multiple Endocrine Neoplasia Type 1 , Neoplasm Metastasis , Neuroendocrine Tumors , Prognosis , Zollinger-Ellison Syndrome
15.
Rev. am. med. respir ; 18(4): 239-244, dic. 2018. ilus, tab
Article in Spanish | LILACS | ID: biblio-977183

ABSTRACT

Los tumores de timo son formaciones poco frecuentes que constituyen el 50% de las masas ocupantes del mediastino anterior, con una incidencia de 0.5/millón personas/año. Componen un grupo heterogéneo de lesiones, con una amplia gradación de aspectos morfológicos siendo el timoma y el carcinoma de timo los más frecuentes. Sin embargo, hay otros subtipos más raros como los timolipomas, timomas quísticos, linfomas, tumores de células germinales y los carcinoides típicos y atípicos. Estos últimos representan el 2% de los tumores de timo1, 2. Los tumores neuroendocrinos en el timo, fueron descriptos por primera vez por Rosai e Higa3 . El número total de casos reportados internacionalmente hasta la fecha es de aproximadamente 400 y el carcinoide atípico de esta glándula constituye un grupo muy poco frecuente entre éstos, con una incidencia anual cercana al 0.18/1.000.000 de personas. El número total de casos de carcinoides atípicos de timo publicados internacionalmente hasta la fecha es algo mayor de 1004, 5 . Con la finalidad de contribuir a la bibliografía, se presenta una observación de carcinoide atípico de timo


Subject(s)
Thymus Neoplasms , Carcinoid Tumor , Neuroendocrine Tumors
16.
Acta méd. colomb ; 43(3): 161-164, jul.-set. 2018. graf
Article in Spanish | LILACS, COLNAL | ID: biblio-983699

ABSTRACT

Resumen Los tumores neuroendocrinos son neoplasias infrecuentes y de abordaje complejo. Actualmente se necesitan más ensayos clínicos aleatorizados para establecer el manejo óptimo de los pacientes afectados por metástasis hepáticas no resecables. Aportamos un caso de TNE metastásico en el que se indicó trasplante hepático por sintomatología derivada del síndrome carcinoide no controlable con el tratamiento médico habitual. (Acta Med Colomb 2018; 43: 161-164).


Abstract Neuroendocrine tumors are infrequent neoplasms with a complex approach. Currently, more randomized clinical trials are needed to establish the optimal management of patients affected by unresectable liver metastases. A case of metastatic NET in which hepatic transplantation was indicated due to symptoms derived from the carcinoid syndrome that cannot be controlled with the usual medical treatment is provided.


Subject(s)
Humans , Male , Adult , Carcinoid Tumor , Neurosecretory Systems , Somatostatin , Liver Transplantation , Neoplasm Metastasis
17.
Rev. Assoc. Med. Bras. (1992) ; 64(1): 15-18, Jan. 2018. graf
Article in English | LILACS | ID: biblio-896418

ABSTRACT

Summary We describe the case of a female patient, 21 years old, complaining of dyspnea attacks and wheezing 2 years ago. Chest radiography showed volume loss in the left lower lobe and ipsilateral retrocardiac triangular basal opacity. CT scan showed an extensive solid mass with apex protruding into the left main and lower lobar bronchi, causing distal atelectasis. Histopathological and immunohistochemical study of transbronchial biopsy of the lesion revealed a typical carcinoid tumor, confirmed after tumor resection with total left pneumectomy.


Resumo Descrevemos um caso de paciente do gênero feminino, 21 anos, apresentando crises de dispneia e sibilância há 2 anos. Radiografia torácica evidenciou perda volumétrica do lobo inferior esquerdo e opacidade triangular basal retrocardíaca ipsilateral. Tomografia computadorizada mostrou formação expansiva sólida com ápice protruindo para o interior dos brônquios principal e lobar inferior esquerdos, promovendo atelectasia distal. Estudos anatomopatológico e imuno-histoquímico após biópsia transbrônquica da lesão diagnosticaram um tumor carcinoide típico, confirmado após ressecção tumoral com pneumectomia total esquerda.


Subject(s)
Humans , Female , Adult , Young Adult , Carcinoid Tumor/diagnostic imaging , Lung Neoplasms/diagnostic imaging , Biopsy , Carcinoid Tumor/pathology , Tomography, X-Ray Computed , Lung Neoplasms/pathology
18.
Article in Chinese | WPRIM | ID: wpr-774466

ABSTRACT

Both malignant tumors derived from gastrointestinal tract and metastasis from peritoneal spread, hematogenous dissemination and lymph node can lead to acute abdomen. Such acute abdomen patients have poor prognosis, high mortality, and complex clinical manifestations. It is difficult to make a correct diagnosis in clinical practice. Recent studies show that gastrointestinal tumors are associated with clinical emergency. Malignant gastrointestinal tumors mostly result in obstruction, so upper gastrointestinal contrast for gastric cancer and post-enhanced CT for colon cancer are recommended; gastrointestinal stromal tumors usually cause bleeding, so computed tomography angiography (CTA) is the first choice for examination; primary gastrointestinal lymphoma tends to cause perforation and usually occurs in small intestine, so CT is the first examination for patients with ischemic acute abdomen, and post-enhanced CT is essential to exclude small intestine carcinoid because of its rising incidence in recent years. The possibility of gastrointestinal metastasis should be kept in mind for patients with cancer presenting acute abdomen. This article focuses on the imaging features of common gastrointestinal tumors and their acute obstruction, perforation, and hemorrhage, and aims to improve the understanding of such symptoms in clinical practice so that correct diagnosis and treatment can be made in time.


Subject(s)
Abdomen, Acute , Diagnostic Imaging , Carcinoid Tumor , Diagnostic Imaging , Gastrointestinal Stromal Tumors , Diagnostic Imaging , Humans , Intestinal Neoplasms , Diagnostic Imaging , Intestines , Diagnostic Imaging
19.
Article in English | WPRIM | ID: wpr-787003

ABSTRACT

Metaiodobenzylguanidine (MIBG) is structurally similar to the neurotransmitter norepinephrine and specifically targets neuroendocrine cells including some neuroendocrine tumors. Iodine-131 (I-131)-labeled MIBG (I-131 MIBG) therapy for neuroendocrine tumors has been performed for more than a quarter-century. The indications of I-131 MIBG therapy include treatment-resistant neuroblastoma (NB), unresectable or metastatic pheochromocytoma (PC) and paraganglioma (PG), unresectable or metastatic carcinoid tumors, and unresectable or metastatic medullary thyroid cancer (MTC). I-131 MIBG therapy is one of the considerable effective treatments in patients with advanced NB, PC, and PG. On the other hand, I-131 MIBG therapy is an alternative method after more effective novel therapies are used such as radiolabeled somatostatin analogs and tyrosine kinase inhibitors in patients with advanced carcinoid tumors and MTC. No-carrier-aided (NCA) I-131 MIBG has more favorable potential compared to the conventional I-131 MIBG. Astatine-211-labeled meta-astatobenzylguanidine (At-211 MABG) has massive potential in patients with neuroendocrine tumors. Further studies about the therapeutic protocols of I-131 MIBG including NCA I-131 MIBG in the clinical setting and At-211 MABG in both the preclinical and clinical settings are needed.


Subject(s)
3-Iodobenzylguanidine , Carcinoid Tumor , Consensus , Hand , Humans , Methods , Neuroblastoma , Neuroendocrine Cells , Neuroendocrine Tumors , Neurotransmitter Agents , Norepinephrine , Paraganglioma , Pheochromocytoma , Protein-Tyrosine Kinases , Somatostatin , Thyroid Neoplasms
20.
Cancer Research and Treatment ; : 1343-1350, 2018.
Article in English | WPRIM | ID: wpr-717518

ABSTRACT

PURPOSE: The aim of this study was to evaluate recent trends in gastric cancer incidence according to the age, sex, and tumor location in the Korean population. MATERIALS AND METHODS: Using data from the Korea Central Cancer Registry between 1999 and 2014, gastric cancer incidence, annual percent changes, and male-to-female incidence rate ratios (IRRs) according to tumorlocationwere determined. The distribution of disease extent according to the tumor location and its changes between 2006 and 2014 were also analyzed. RESULTS: Incidence of gastric cancer was stable until 2011 and decreased between 2011 and 2014. The age-standardized incidence rate of gastric cancer was 43.6 (per 100,000) in 1999 and 35.8 in 2014. The proportion of cardia/fundus cancer remained stable (5.9% to 7.1%), and that of body cancer increased (35.3% to 43.2%). The male-to-female IRR decreased in most age groups, except for those in their 60s. In the distribution of disease extent, the proportion of localized disease increased, and regional and distant disease decreased in all tumor locations (53.9% to 66.0%, 31.4% to 22.5%, and 14.8% to 11.5%, respectively; p < 0.001). For histological type, the proportion of carcinoid tumor and non-epithelial tumor increased (0.3% to 1.0%, and 0.8% to 1.4%, respectively). CONCLUSION: In the 15 years from 1999 through 2014, age-standardized incidence of gastric cancer started to decrease from 2012, and the proportion of cardia/fundus cancer remained unchanged. The trend of increasing localized cancer was observed in all tumor locations.


Subject(s)
Carcinoid Tumor , Epidemiology , Humans , Incidence , Korea , Stomach Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL